DSM sells pharmaceutical production site in Michigan (USA) to Albemarle
In December of last year DSM decided on exit by closure or divestment of the South Haven site, which is focused on the production of generic active pharmaceutical ingredients. The divestiture of the South Haven site is an integral part of DSM Pharmaceutical Products' asset base restructuring, as mentioned in DSM's Vision 2010.
Most read news
Other news from the department business & finance
These products might interest you
AZURA Purifier + LH 2.1 by KNAUER
Preparative Liquid Chromatography - New platform for more throughput
Save time and improve reproducibility during purification
Pharmaceutical Substances by Thieme Verlag
Look up Industrial Syntheses of 2,600 APIs
Your tool for Syntheses, Patents and Applications – Pharmaceutical Substances
Get the chemical industry in your inbox
From now on, don't miss a thing: Our newsletter for the chemical industry, analytics, lab technology and process engineering brings you up to date every Tuesday and Thursday. The latest industry news, product highlights and innovations - compact and easy to understand in your inbox. Researched by us so you don't have to.